🔎 Trials Near Me

Akèy › Kansè Ezofajyen › Minnesota › Rochester

Etid klinik pou Kansè Ezofajyen nan Rochester, MN

11 etid pou Kansè Ezofajyen ap chèche patisipan nan sit nan ak bò kote Rochester (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Pan-tumor MRD Study

Ap rekriteEtid obsèvasyon
  • Mayo Clinic, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT06605404

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Ap rekriteFaz 1
  • Mayo Clinic - Rochester, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07213791

Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.

Ap rekriteFaz 3
  • Mayo Clinic Rochester, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07217704

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Ap rekriteEtid obsèvasyon
  • Mayo Clinic (Rochester), Rochester
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT05059444

Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Mayo Clinic, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Aug 10, 2026 · NCT00288119

Lead-212 PSV359 Therapy for Patients With Solid Tumors

Ap rekriteFaz 1/2
  • Mayo Clinic in Rochester, Minnesota, Rochester
Laj 18 a 90 · Tout sèks · Mizajou Jul 6, 2026 · NCT06710756

Mayo Clinic Upper Digestive Disease Survey

Ap rekriteEtid obsèvasyon
  • Mayo Clinic, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Mar 30, 2026 · NCT02530983

Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform

Ap rekriteEtid obsèvasyon
  • Mayo Clinic in Rochester, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Mar 12, 2026 · NCT06349642

Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma

Ap rekriteVolontè an sante akeyi
  • Mayo Clinic Rochester, Rochester
Laj 18 a 90 · Tout sèks · Mizajou Jan 26, 2026 · NCT03961945

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Mayo Clinic, Rochester
Laj 40 ak plis · Tout sèks · Mizajou Jan 20, 2026 · NCT05366881

Etid Kansè Ezofajyen nan lòt vil

Lòt etid nan Rochester

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.